Presymptomatic diagnosis of neurofibromatosis 2 using linked genetic markers, neuroimaging, and ocular examinations

M. E. Baser, V. F. Mautner, N. K. Ragge, Alex Nechiporuk, V. M. Riccardi, J. Klein, J. Sainz, S. M. Pulst

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Neurofibromatosis 2 (NF2) is an autosomal dominant disorder that causes nervous system tumors and ocular abnormalities such as early-onset lenticular opacities. We assessed the clinical spectrum of NF2 at the time of presymptomatic DNA diagnosis in at-risk first-degree relatives. We studied five multigeneration NF2 families with short tandem repeat markers near the NF2 gene (NF2); gadolinium-enhanced high-resolution magnetic resonance imaging (GE-MRI); and ocular, dermatologic, and neurologic examinations. Eleven of 31 asymptomatic at-risk first-degree relatives were predicted by segregation analysis to be NF2 mutation carriers. Nine of the 11 NF2 mutation carriers were clinically evaluated. Four mutation carriers, including a 7- year-old, had vestibular schwannomas, early-onset cataracts, or both. However, five mutation carriers did not have clinical abnormalities, including a 38-year-old with normal cranial and spinal GE-MRIs and a normal ocular examination. These results indicate that clinical abnormalities can be present in young, but absent in middle-aged, presymptomatic NF2 mutation carriers. By identifying presymptomatic NF2 mutation carriers, DNA diagnosis of NF2 can improve genetic counseling and clinical management, and possibly reduce psychosocial difficulties in at-risk individuals.

Original languageEnglish (US)
Pages (from-to)1269-1277
Number of pages9
JournalNeurology
Volume47
Issue number5
StatePublished - Nov 1996
Externally publishedYes

Fingerprint

Neurofibromatosis 2
Genetic Markers
Neuroimaging
Mutation
Neurofibromatosis 2 Genes
Eye Abnormalities
Nervous System Neoplasms
Nervous System Malformations
Acoustic Neuroma
DNA
Genetic Counseling
Neurologic Examination
Gadolinium
Microsatellite Repeats
Cataract
Magnetic Resonance Imaging

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Baser, M. E., Mautner, V. F., Ragge, N. K., Nechiporuk, A., Riccardi, V. M., Klein, J., ... Pulst, S. M. (1996). Presymptomatic diagnosis of neurofibromatosis 2 using linked genetic markers, neuroimaging, and ocular examinations. Neurology, 47(5), 1269-1277.

Presymptomatic diagnosis of neurofibromatosis 2 using linked genetic markers, neuroimaging, and ocular examinations. / Baser, M. E.; Mautner, V. F.; Ragge, N. K.; Nechiporuk, Alex; Riccardi, V. M.; Klein, J.; Sainz, J.; Pulst, S. M.

In: Neurology, Vol. 47, No. 5, 11.1996, p. 1269-1277.

Research output: Contribution to journalArticle

Baser, ME, Mautner, VF, Ragge, NK, Nechiporuk, A, Riccardi, VM, Klein, J, Sainz, J & Pulst, SM 1996, 'Presymptomatic diagnosis of neurofibromatosis 2 using linked genetic markers, neuroimaging, and ocular examinations', Neurology, vol. 47, no. 5, pp. 1269-1277.
Baser, M. E. ; Mautner, V. F. ; Ragge, N. K. ; Nechiporuk, Alex ; Riccardi, V. M. ; Klein, J. ; Sainz, J. ; Pulst, S. M. / Presymptomatic diagnosis of neurofibromatosis 2 using linked genetic markers, neuroimaging, and ocular examinations. In: Neurology. 1996 ; Vol. 47, No. 5. pp. 1269-1277.
@article{d93a54e5dc4349f4a17e52660898d775,
title = "Presymptomatic diagnosis of neurofibromatosis 2 using linked genetic markers, neuroimaging, and ocular examinations",
abstract = "Neurofibromatosis 2 (NF2) is an autosomal dominant disorder that causes nervous system tumors and ocular abnormalities such as early-onset lenticular opacities. We assessed the clinical spectrum of NF2 at the time of presymptomatic DNA diagnosis in at-risk first-degree relatives. We studied five multigeneration NF2 families with short tandem repeat markers near the NF2 gene (NF2); gadolinium-enhanced high-resolution magnetic resonance imaging (GE-MRI); and ocular, dermatologic, and neurologic examinations. Eleven of 31 asymptomatic at-risk first-degree relatives were predicted by segregation analysis to be NF2 mutation carriers. Nine of the 11 NF2 mutation carriers were clinically evaluated. Four mutation carriers, including a 7- year-old, had vestibular schwannomas, early-onset cataracts, or both. However, five mutation carriers did not have clinical abnormalities, including a 38-year-old with normal cranial and spinal GE-MRIs and a normal ocular examination. These results indicate that clinical abnormalities can be present in young, but absent in middle-aged, presymptomatic NF2 mutation carriers. By identifying presymptomatic NF2 mutation carriers, DNA diagnosis of NF2 can improve genetic counseling and clinical management, and possibly reduce psychosocial difficulties in at-risk individuals.",
author = "Baser, {M. E.} and Mautner, {V. F.} and Ragge, {N. K.} and Alex Nechiporuk and Riccardi, {V. M.} and J. Klein and J. Sainz and Pulst, {S. M.}",
year = "1996",
month = "11",
language = "English (US)",
volume = "47",
pages = "1269--1277",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Presymptomatic diagnosis of neurofibromatosis 2 using linked genetic markers, neuroimaging, and ocular examinations

AU - Baser, M. E.

AU - Mautner, V. F.

AU - Ragge, N. K.

AU - Nechiporuk, Alex

AU - Riccardi, V. M.

AU - Klein, J.

AU - Sainz, J.

AU - Pulst, S. M.

PY - 1996/11

Y1 - 1996/11

N2 - Neurofibromatosis 2 (NF2) is an autosomal dominant disorder that causes nervous system tumors and ocular abnormalities such as early-onset lenticular opacities. We assessed the clinical spectrum of NF2 at the time of presymptomatic DNA diagnosis in at-risk first-degree relatives. We studied five multigeneration NF2 families with short tandem repeat markers near the NF2 gene (NF2); gadolinium-enhanced high-resolution magnetic resonance imaging (GE-MRI); and ocular, dermatologic, and neurologic examinations. Eleven of 31 asymptomatic at-risk first-degree relatives were predicted by segregation analysis to be NF2 mutation carriers. Nine of the 11 NF2 mutation carriers were clinically evaluated. Four mutation carriers, including a 7- year-old, had vestibular schwannomas, early-onset cataracts, or both. However, five mutation carriers did not have clinical abnormalities, including a 38-year-old with normal cranial and spinal GE-MRIs and a normal ocular examination. These results indicate that clinical abnormalities can be present in young, but absent in middle-aged, presymptomatic NF2 mutation carriers. By identifying presymptomatic NF2 mutation carriers, DNA diagnosis of NF2 can improve genetic counseling and clinical management, and possibly reduce psychosocial difficulties in at-risk individuals.

AB - Neurofibromatosis 2 (NF2) is an autosomal dominant disorder that causes nervous system tumors and ocular abnormalities such as early-onset lenticular opacities. We assessed the clinical spectrum of NF2 at the time of presymptomatic DNA diagnosis in at-risk first-degree relatives. We studied five multigeneration NF2 families with short tandem repeat markers near the NF2 gene (NF2); gadolinium-enhanced high-resolution magnetic resonance imaging (GE-MRI); and ocular, dermatologic, and neurologic examinations. Eleven of 31 asymptomatic at-risk first-degree relatives were predicted by segregation analysis to be NF2 mutation carriers. Nine of the 11 NF2 mutation carriers were clinically evaluated. Four mutation carriers, including a 7- year-old, had vestibular schwannomas, early-onset cataracts, or both. However, five mutation carriers did not have clinical abnormalities, including a 38-year-old with normal cranial and spinal GE-MRIs and a normal ocular examination. These results indicate that clinical abnormalities can be present in young, but absent in middle-aged, presymptomatic NF2 mutation carriers. By identifying presymptomatic NF2 mutation carriers, DNA diagnosis of NF2 can improve genetic counseling and clinical management, and possibly reduce psychosocial difficulties in at-risk individuals.

UR - http://www.scopus.com/inward/record.url?scp=0029989418&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029989418&partnerID=8YFLogxK

M3 - Article

C2 - 8909442

AN - SCOPUS:0029989418

VL - 47

SP - 1269

EP - 1277

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 5

ER -